In one of the latest studies, researchers from Iran analyzed the impact of a proprietary formula containing plant-based CBD and THC in a 10:1 ratio, which was created by Yas Daru, a pharmaceutical firm in Tehran. It was given to 50 diabetic patients diagnosed with type 2 diabetes sublingually to help keep glucose as well as cholesterol levels in check. The study participants administered the sublingual spray twice a day for 8 weeks.
Cannabis moves fast. New strains appear every season, each promising louder flavors, bigger yields, or…
What do you give someone who already has everything? That’s the question Distinctive Assets, the…
The road into the Mzintlava River Valley is not on any investment map. It bends…
On February 9th, 2026, the New York Times editorial board published a piece titled "It's…
A point-by-point look at SAM’s New York report finds a familiar pattern: selective data, overstated…
"The War on Drugs" is a 12-track musical history project chronicling America's century-long crusade against…